TSX:BLU (Bellus Health)
About BLU
BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.
Bellus Health (TSX: BLU) Latest News

Coronavirus
Is Bellus Health Stock Still a Buy After 30% Earnings Jump?

Metals and Mining Stocks
TSX Today: What to Watch for in Stocks on Tuesday, December 14

Coronavirus
Why BELLUS Health Exploded 60% on Monday

Investing
The 50% Healthcare Index Dip and a Silver Lining

Stocks for Beginners
2 Canadian Healthcare Stocks That Are All-Stars in the Making

Stocks for Beginners
4 Canadian Stocks That Could Soar 68% or More According to Bay Street

Investing
Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!

Energy Stocks
3 Bargain TSX Stocks to Buy While They’re Low

Cannabis Stocks
3 Top Growth Stocks to Own Before They Take Off

Dividend Stocks
Got $2,000? 4 Top Stocks to Buy This Month

Investing
TFSA Investors: This Pharma Stock Could Rise Significantly
